Cobicistat-boosted elvitegravir-based fixed-dose combination antiretroviral therapy for HIV infection.
Temesgen Z.
Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2012.48.12.1895682 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cobicistat. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
10 träffarElvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.
Olin JL, Spooner LM, Klibanov OM.
Ann Pharmacother · comparative study; review; journal article · DOI 10.1345/aph.1r468Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.
German P, Liu HC, Szwarcberg J, Hepner M, Andrews J, Kearney BP, Mathias A.
J Acquir Immune Defic Syndr · randomized controlled trial; journal article · DOI 10.1097/qai.0b013e3182645648Tolerability of HIV integrase inhibitors.
Lee FJ, Carr A.
Curr Opin HIV AIDS · review; journal article · DOI 10.1097/coh.0b013e328356682aCobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro.
Lepist EI, Phan TK, Roy A, Tong L, Maclennan K, Murray B, Ray AS.
Antimicrob Agents Chemother · brief-report; journal article · DOI 10.1128/aac.01089-12Update on raltegravir and the development of new integrase strand transfer inhibitors.
Shamroe CL, Bookstaver PB, Rokas KE, Weissman SB.
South Med J · research support, non-u.s. gov't; review; journal article · DOI 10.1097/smj.0b013e318258c847Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
Llibre JM, Clotet B.
AIDS Rev · research support, non-u.s. gov't; review; journal articleClinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir.
Ramanathan S, Mathias AA, German P, Kearney BP.
Clin Pharmacokinet · research support, non-u.s. gov't; review; journal article · DOI 10.2165/11584570-000000000-00000Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV.
German P, Warren D, West S, Hui J, Kearney BP.
J Acquir Immune Defic Syndr · randomized controlled trial; journal article · DOI 10.1097/qai.0b013e3181eb376bPharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity.
Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP.
Clin Pharmacol Ther · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1038/clpt.2009.228